Philip Dormitzer
Philip Dormitzer
Verified email at pfizer.com
Title
Cited by
Cited by
Year
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine
FP Polack, SJ Thomas, N Kitchin, J Absalon, A Gurtman, S Lockhart, ...
New England Journal of Medicine, 2020
44672020
Safety and immunogenicity of two RNA-based Covid-19 vaccine candidates
EE Walsh, RW Frenck Jr, AR Falsey, N Kitchin, J Absalon, A Gurtman, ...
New England Journal of Medicine 383 (25), 2439-2450, 2020
10342020
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
MJ Mulligan, KE Lyke, N Kitchin, J Absalon, A Gurtman, S Lockhart, ...
Nature 586 (7830), 589-593, 2020
8192020
COVID-19 vaccine BNT162b1 elicits human antibody and TH 1 T cell responses
U Sahin, A Muik, E Derhovanessian, I Vogler, LM Kranz, M Vormehr, ...
Nature 586 (7830), 594-599, 2020
6362020
Nonviral delivery of self-amplifying RNA vaccines
AJ Geall, A Verma, GR Otten, CA Shaw, A Hekele, K Banerjee, Y Cu, ...
Proceedings of the National Academy of Sciences 109 (36), 14604-14609, 2012
4172012
Near-atomic resolution using electron cryomicroscopy and single-particle reconstruction
X Zhang, E Settembre, C Xu, PR Dormitzer, R Bellamy, SC Harrison, ...
Proceedings of the National Academy of Sciences 105 (6), 1867-1872, 2008
4022008
Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin
JRR Whittle, R Zhang, S Khurana, LR King, J Manischewitz, H Golding, ...
Proceedings of the National Academy of Sciences 108 (34), 14216-14221, 2011
4002011
The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site
PR Dormitzer, ZYJ Sun, G Wagner, SC Harrison
The EMBO journal 21 (5), 885-897, 2002
3622002
SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells
IC Huang, BJ Bosch, F Li, W Li, KH Lee, S Ghiran, N Vasilieva, ...
Journal of Biological Chemistry 281 (6), 3198-3203, 2006
3372006
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
X Xie, Y Liu, J Liu, X Zhang, J Zou, CR Fontes-Garfias, H Xia, ...
Nature Medicine 27 (4), 620-621, 2021
3042021
Neutralizing activity of BNT162b2-elicited serum
Y Liu, J Liu, H Xia, X Zhang, CR Fontes-Garfias, KA Swanson, H Cai, ...
New England Journal of Medicine 384 (15), 1466-1468, 2021
2912021
Neutralization of SARS-CoV-2 lineage B. 1.1. 7 pseudovirus by BNT162b2 vaccine–elicited human sera
A Muik, AK Wallisch, B Sänger, KA Swanson, J Mühl, W Chen, H Cai, ...
Science 371 (6534), 1152-1153, 2021
2852021
Part II: The viruses–the double stranded RNA viruses-family Reoviridae
H Attoui, J Becnel, S Belaganahalli, M Bergoin, CP Brussaard, ...
Elsevier Academic Press; San Diego, 2012
2632012
Atomic model of an infectious rotavirus particle
EC Settembre, JZ Chen, PR Dormitzer, N Grigorieff, SC Harrison
The EMBO journal 30 (2), 408-416, 2011
2622011
Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers
KA Swanson, EC Settembre, CA Shaw, AK Dey, R Rappuoli, CW Mandl, ...
Proceedings of the National Academy of Sciences 108 (23), 9619-9624, 2011
2452011
Structural rearrangements in the membrane penetration protein of a non-enveloped virus
PR Dormitzer, EB Nason, BVV Prasad, SC Harrison
Nature 430 (7003), 1053-1058, 2004
2412004
Nemaline myopathy with minicores caused by mutation of the CFL2 gene encoding the skeletal muscle actin–binding protein, cofilin-2
PB Agrawal, RS Greenleaf, KK Tomczak, VL Lehtokari, ...
The American Journal of Human Genetics 80 (1), 162-167, 2007
2382007
Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab
ST Aoki, EC Settembre, SD Trask, HB Greenberg, SC Harrison, ...
Science 324 (5933), 1444-1447, 2009
2352009
Strategic priorities for respiratory syncytial virus (RSV) vaccine development
LJ Anderson, PR Dormitzer, DJ Nokes, R Rappuoli, A Roca, BS Graham
Vaccine 31, B209-B215, 2013
2212013
Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody
AG Schmidt, H Xu, AR Khan, T O’Donnell, S Khurana, LR King, ...
Proceedings of the National Academy of Sciences 110 (1), 264-269, 2013
1882013
The system can't perform the operation now. Try again later.
Articles 1–20